Please login to the form below
Ipsen
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Ipsen's 2013 oncology sales performance.
Ipsen reports positive phase 3 data for Onivyde in pancreatic cancer
Ipsen has announced that its phase 3 study of Onivyde (irinotecan liposome injection), as part of an investigational treatment regimen called Nalirifox, met its primary endpoint of improvement in overall survival ... Ipsen’s executive vice president
Ipsen to acquire rare disease specialist Albireo in deal worth over $950m
Ipsen has announced it will acquire rare disease specialist Albireo for $952m in a deal that is set to strengthen the French biopharma’s liver disease pipeline. ... Through the acquisition, Ipsen will gain access to Bylvay (odevixibat), a non-systemic
Putting the ‘Real Man’ with Prostate Cancer at the Heart of Treatment Decisions and Conversations
Ipsen is a global leader in PCa treatment with a strong reputation for physician and patient support. ... Ipsen aims to bring honesty, authenticity, and individualisation to the heart of conversations and treatment decisions relating to PCa.
Flexterity
Putting the ‘Real Man’ with Prostate Cancer at the Heart of Treatment Decisions and Conversations - by Ipsen with support from Uptake Strategies.
Winning Hearts and Minds – How Pfizer UK Oncology are Giving Cancer Patients, Carers and their Families a Voice
Putting the ‘Real Man’ with Prostate Cancer at the Heart of Treatment Decisions and Conversations - by Ipsen with support from Uptake Strategies.
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- Europe’s cancer community publishes new report on transforming patient care
- EU outlines measures to mitigate antibiotic shortage across Europe
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- EU to revise pharmaceuticals law amid antibiotic shortages
- European MPs call for urgent action against antimicrobial resistance
- The role of medical communications in building credibility for healthtech
PMHub
KVA
KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
